Document is current
Any future updates will be listed below
-
Authors
Wang, Bei-Ying
Zhang, Xiao
Li, Ting-Tian
Qin, Wei-Wei
Liu, Xiang
Lu, Kong-Miao
Sun, Li-Xin
Han, Wei
-
Funding
Funding for this research was provided by:
Qingdao Science and Technology Benefiting the People Demonstration Special Project (23-2-8-smjk-14-nsh)
the National Natural Science Foundation of China (82202384)
- License Information
-
More Information
Article History
Received: 28 February 2025
Accepted: 18 July 2025
First Online: 26 July 2025
Declarations
:
: All animal experiments were approved by the Ethics Committee for the Use of Animals of Qingdao Municipal Hospital. (Approval No. XM: 2023–001 “Ultrasound-targeted adjuvant stem cell therapy in the comprehensive management of respiratory critical illnesses” approved on Apr 28, 2024). The original source (Qingdao Zhong De Hua Da Cell Technology Co) has confirmed that there was initial ethical approval for collection of human cells, and that the donors had signed informed consent.
: All authors given consent to publish the research data.
: The authors declare that they have no competing interests.
